Full-Time

Regional Director

Confirmed live in the last 24 hours

Ceribell

Ceribell

201-500 employees

EEG devices for monitoring brain activity

Healthcare

Compensation Overview

$200kAnnually

+ Uncapped Variable Compensation + Equity

Senior, Expert

Denver, CO, USA

Role covers multiple states in the Mid-Atlantic Region.

Category
Strategic Account Management
Sales & Account Management
Requirements
  • Bachelor's degree in Business Administration, Life Sciences, or related field (advanced degree preferred).
  • 10+ years of experience in medical device sales, with a demonstrated track record of success in selling into complex and disruptive environments.
  • 5+ years of leadership experience, preferably in a regional or national sales management role.
  • Strong understanding of the healthcare industry
  • Prior experience selling into the ED and/or ICU
  • Excellent communication, presentation, and negotiation skills.
  • Proven ability to develop and execute strategic sales plans, drive revenue growth, and exceed targets.
  • Ability to travel within the assigned region as needed.
Responsibilities
  • Directly manage a team of Territory Managers, providing guidance, support, and mentorship to ensure the achievement of sales targets and objectives.
  • Develop and implement strategic sales plans to drive new business acquisition and market expansion within the region.
  • Cultivate and maintain strong relationships with key customers, KOLs (Key Opinion Leaders), and key stakeholders within the healthcare ecosystem.
  • Conduct thorough market analysis to identify opportunities for growth and differentiation.
  • Collaborate closely with cross-functional teams, including Marketing, Product Development, and Customer Success, Account Management to align sales strategies with overall business objectives.
  • Track, analyze, and report on sales performance metrics, providing regular updates to senior management.
  • Facilitate training sessions and workshops to enhance the skills and capabilities of the sales team, ensuring continuous professional development.
  • Ensure compliance with all relevant regulatory requirements and company policies.

Ceribell focuses on developing medical devices that utilize electroencephalogram (EEG) technology to monitor brain activity. Their main product, the Ceribell EEG Headband and Recorder, is designed for use by trained healthcare providers in professional settings. These devices help gather important data on a patient's brain activity, which is essential for diagnosing and treating neurological conditions, particularly in urgent situations like Nonconvulsive Status Epilepticus (NCSE). Unlike some other medical devices, the Ceribell EEG Recorder does not provide diagnostic conclusions or automated alerts; instead, it serves as a tool for healthcare professionals to collect data for interpretation. Ceribell differentiates itself by focusing on the speed of data collection, which is critical in time-sensitive medical scenarios. The company's goal is to enhance the ability of healthcare providers to make informed treatment decisions quickly, ultimately improving patient outcomes.

Company Stage

Series C

Total Funding

$146.9M

Headquarters

Mountain View, California

Founded

2014

Growth & Insights
Headcount

6 month growth

11%

1 year growth

25%

2 year growth

63%
Simplify Jobs

Simplify's Take

What believers are saying

  • Ceribell's recent $102 million equity investment and $50 million financing round indicate strong financial backing for expansion and product development.
  • The appointment of experienced leaders like Sean Manni and Joshua Copp positions the company for strategic growth and operational excellence.
  • Recognition by Fast Company as one of the World's Most Innovative Companies highlights Ceribell's industry impact and potential for continued innovation.

What critics are saying

  • The reliance on healthcare providers to interpret EEG data may limit the device's adoption in settings with less specialized staff.
  • The competitive landscape in medical devices and AI-powered diagnostics could pose challenges to Ceribell's market share.

What makes Ceribell unique

  • Ceribell's AI-powered point-of-care EEG system is a first-of-its-kind technology, setting it apart from traditional EEG devices.
  • The company's focus on rapid, easy-to-use brain monitoring solutions for time-critical conditions like NCSE provides a unique value proposition.
  • FDA Breakthrough Device Designation for delirium detection further validates Ceribell's innovative approach in neurodiagnostics.

Help us improve and share your feedback! Did you find this helpful?